Pharmaceutical Lipids Market - Lipids are also gaining substantial demand for developing cancer drug delivery systems

Chronic and viral diseases continue to cast their ugly shadow on the world with high transmission rates and increasing fatalities.

Chronic and viral diseases continue to cast their ugly shadow on the world with high transmission rates and increasing fatalities. To bring down the rate of fatalities and provide effective treatment through cutting-edge drugs is an essential factor. Lipids play an important role in the drug delivery process. Therefore, based on this aspect, the pharmaceutical lipids market may gain considerable momentum over the forecast period of 2019-2029. The growing threat of the novel coronavirus disease may bring exponential growth for the pharmaceutical lipids market.

On the basis of product, the pharmaceutical lipids market can be classified into sphingolipids, cholesterol, fatty acids, triglycerides, and phospholipids. Hospitals, pharmacies, retail stores, and drug stores are categorized as distribution channels of the pharmaceutical lipids market.

Get a glimpse of the in-depth analysis through our Report Brochure

This pharmaceutical lipids market report analyses diverse factors that are associated with bringing growth. Some major aspects such as emerging trends, mergers and acquisitions, and the geographical dimensions of the pharmaceutical lipids market have been thoroughly studied in this report. The stakeholders can gain good advantage from this report on the pharmaceutical lipids market. Furthermore, this report also carries an analysis of the COVID-19 impact on the pharmaceutical lipids market.

Pharmaceutical Lipids Market: Competitive Aspects

The intensified competition from a plethora of local and international players in the pharmaceutical lipids market places it under a fragmented landscape. The players in the pharmaceutical lipids market are constantly involved in research and development activities for the exploration of new formulations that can treat various diseases.

The COVID-19 outbreak has brought tremendous loss to the global populace with increasing infections and high fatality rates. Thus, many biopharma firms have braced themselves for finding an effective treatment for COVID-19. Lipids form an important component in the formulation of an efficient treatment option. Therefore, the demand for lipids has gone up and is eventually proving to be a boon for the pharmaceutical lipids market.

Some key participants in the pharmaceutical lipids market are Esperion Therapeutics, Avanti Polar Lipids, Cayman Chemical, Cerbios-Pharma, CordenPharma International, Sancilio & Company, and VAV Life Sciences Merck.

Pharmaceutical Lipids Market: Mergers and Acquisitions

Mergers, acquisitions, partnerships, collaborations, and joint ventures bring immense growth opportunities for the pharmaceutical lipids market. These activities also help in strengthening the foothold of the players in the pharmaceutical lipids market. Here are some recent mergers and acquisitions in the pharmaceutical lipids market.

Expanding operations in future? To get the perfect launch ask for a custom report

  • Croda International announced to acquire Avanti Polar Lipids for $185 mn, plus an additional; $75 mn depending on financial performance.
  • Abitec Corporation recently acquired Larodan AB, a manufacturer of high purity research-grade lipids.
  • CordenPharma extended the agreement with Moderna Inc. to supply lipids required for producing Moderna’s COVID-19 vaccine candidate

Pharmaceutical Lipids Market: Key Trends

The development of a COVID-19 vaccine is in clinical trial phase and numerous pharmaceutical companies have joined the race with their vaccine candidates. Pharmaceutical lipids may observe escalating demand from the companies in the race for finding an effective COVID-19 treatment. Therefore, this factor brings immense growth prospects for the pharmaceutical lipids market.

Lipids are also gaining substantial demand for developing cancer drug delivery systems. For instance, Cellectar Biosciences is examining the potential of CLR 131, a phospholipid drug-conjugate to cure cancer. It has shown efficacy in treating B-cell malignancies, including multiple myeloma. Such developments bring prodigious growth for the pharmaceutical lipids market.

Pharmaceutical Lipids Market: Geographical Insights

The pharmaceutical lipids market is geographically segmented into Europe, Latin America, the Middle East and Africa, Europe, and North America. Asia Pacific may help the pharmaceutical lipids market to flutter its wings across the horizon of growth due to a substantial presence of API manufacturers in the region. The swelling number of chronic diseases may also bring extensive growth opportunities for the pharmaceutical lipids market.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6736

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/